Term
|
Definition
Adult/Elderly
3.5-5 g/dL
Children
Premature: 3-4.2 g/dL
Newborn: 3.5-5.4 g/dL
Infant: 4.4-5.4 g/dL
Child 4-5.9 g/dL
Indications: used to evaluate and monitor the disease course in patients with cancer, intestinal or renal protein wasting states, immune disorders, liver dysfunction, impaired nutrition, and chronic edema (Pg 441) |
|
|
Term
Alanine
Aminotransferase (ALT) |
|
Definition
Adults
4-36 units/L
may be 2x that in infants, may be elevated in African Americans, elderly and males, (pg 38) |
|
|
Term
|
Definition
Adults
10-80 mcg/dL
Child
40-80 mcg/dL
Newborns
90-150 mcg/dL
Indications: liver diseases |
|
|
Term
Aspartate
Aminotransferase (AST)
|
|
Definition
Age Value in units/dL
0-5 days 35-140
<3 yrs 15-60
3-6 yrs 15-50
6-12 yrs 10-50
12-18 yrs 10-40
Adults 0-35
increased in elderly
Indications: hepatocellular disease |
|
|
Term
|
Definition
Adult
30-220 units/dL
Newborns
6-65 units/dL
Critical Value: 3 x upper limit
Indication: pancreatitis, ectopic pregnancy, etc. |
|
|
Term
|
Definition
Normal
30-120 units/L (slightly higher in children and elderly)
most sensitive indicator of metastisis to liver, |
|
|
Term
|
Definition
Adult
.3-1 mg/dL
Newborn
1-12 mg/dL
Critical Value: Adult 12 mg/dL; Newborn >15
(pg 131) |
|
|
Term
|
Definition
Age Amount mg/dL
<10 days 7.6-10.4
10 days-2 yrs. 9-10.6
child 8.8-10.8
adult 9-10.5
Older adults have lower levels
Critical values: <6 or >13
Indications: used to evaluate parathyroid function, renal function problems, and cancers
pg 148
|
|
|
Term
|
Definition
Age Amount mg/dL
Adult <200
Child 120-200
Newborn 53-135
Infant 70-175
Indications: used to evaluate risk of coronary heart disease
p166 |
|
|
Term
|
Definition
Age Amount in mg/dL
adult
female .5-1.1
male .6-1.2
Adolescents .5-1
child .3-.7
infant .2-.4
newborn .3-1.2
Critical Values >4
pg.204 |
|
|
Term
Erythrocyte
Sedimentation Rate |
|
Definition
Age Amount in mm/hr
Adult
female </= 20
male </= 15
child </= 10
Newborn 0-2
Indications: used to diagnose conditions associated with inflammation, tissue necrosis, infarct and malignancies
pg 234 |
|
|
Term
|
Definition
Range
Adult 200-400 mg/dL
Newborn 125-300 mg/dL
Critical value: <100
can lead to spontaneous bleeding |
|
|
Term
|
Definition
Age Amount in mg/dL
premi 20-60
Neonate 30-60
Infant 40-90
Child <2 60-100
Child >2 - Adult Fast 70-110
Casual </= 200
Critical Values
Age Amount
Adult
Male <50 or >400
Female <40 or >400
Infant <40
Newborn <30 or >300
pg 267 |
|
|
Term
|
Definition
Range
Fasting < 110 mg/dL
30 min < 200 mg/dL
1 hr < 200 mg/dL
2 hrs < 140
3 hrs 70-115
4 hrs 70-115
urine negative
pg 275
|
|
|
Term
|
Definition
Range
Nondiabetic 4-5.9%
Good Diabetic control <7%
Fair Control 8-9%
Poor Control >9%
pg 280 |
|
|
Term
|
Definition
Age Range in %
Adult
Male 42-52
Female 37-47
Pregnant Female 33
Elderly Values decrease
Child
Newborn 44-64
2-8 weeks 39-59
2-6 months 35-50
6 months - 1 year 29-43
1-6 years 30-40
6-18 years 32-44
Critical Values: <15 or >60 %
Indications:Indirect measure of RBC number and volume.
pg 295 |
|
|
Term
|
Definition
Age Rate in g/dL
Adult
Male 14-18
Female 12-16
Pregnant Female >11
Elderly Values decrease
Child
Newborn 14-24
0-2 weeks 12-20
2-6 months 10-17
6 months-1year 9.5-14
1-6 years 9.5-14
6-18 years 10-15.5
Critical Values: <5 or >20 g/dL
Indications: measures RBC
pg 299
|
|
|
Term
|
Definition
Normal findings show undetectable load
Ranges for HIV pos
% develop AIDS Load (RNA copies)
5.4 <500
16.6 500-3000
31.7 3100-10000
55.2 10001-30000
80 >30000
Pg 316 |
|
|
Term
|
Definition
Age Range in units/L
Newborn 160-450
Infant 100-250
Child 60-170
Adult/elderly 100-190
Indications: An intercellular enzyme used to support diagnosis of injury or disease involving the heart, liver, RBC, kidneys, skeletal muscle, brain and lungs. |
|
|
Term
|
Definition
Normal Findings
0-160 units/L
Indications
Evaluates pancreatic function
p354 |
|
|
Term
|
Definition
Range
Adult 1.3-2.1 mEq/L
Child 1.4-1.7 mEq/L
Newborn 1.4-2 mEq/L
Critical Values: <.5 or >3 mEq/L
Indications: This test is used to identify magnesium levels.
Increased levels indicate renal insufficiency, Addison disease leads to increased aldosterone which increases Mg excretion, Mg antacids , hypothyroidis, major transfusion. Symptoms: lethargy, nausea and vomiting, and slurred speech.
Decreased levels: Malnutrition, malabsorption, hypoparathyroidism leads to decreased Ca absorb therefore decreased Mg absorb, alcoholism increases excretion, chronic renal tubular disease because Mg is reabsorbed in renal tubules, diabetic acidosis treatment causes Mg to fall. Symptoms: weakness, irritability, tetany, EKG changes, delirium and convulsions.
pg 368 |
|
|
Term
|
Definition
Normal Levels: 10-65 pg/mL
Indications: PTH is measured to assist in the evaluation of hypercalcemia or hypocalcemia. It is routinely monitored in patients with chronic renal failure. |
|
|
Term
Partial
Thromboplastin Time |
|
Definition
Normal
aPTT 30-40 seconds
PTT 60-70 seconds
Patients receiving anticoagulant therapy: 1.5-2.5 times control value in seconds.
Critical Value: aPPT >70 sec. PPT >100 sec.
Indications: The PTT test is used to assess the intrinsic system and the common pathway of clot formation. It is also used to monitor heparin therapy. |
|
|
Term
|
Definition
Age Range in mg/dL
Adult 3-4.5
Elderly values decrease
Child 4.5-6.5
Newborn 4.3-9.3
Critical Value: <1 mg/dL
Indications: Investigate parathyroid and calcium abnormalities.
pg 406 |
|
|
Term
|
Definition
Normal Findings
Vary with platelet agonist used
Indications: This test is a measure of platelet function and aids in the evaluation of bleeding disorders
|
|
|
Term
|
Definition
Age Amount in mm^3
Adult/elderly 150,000-400,000
Child 150,000-400,000
Infant 200,000- 475,000
Premature Infants 100,000-300,000
Newborns 150,000-300,000
Critical Values: 9,000 or >1 million/mm^3
Indications: Performed on patients who develop patechiae, spontaneous bleeding, increasingly heavy menses, or thrombocytopenia. It is used to monitor the course of the disease or therapy for thrombocytopenia or bone marrow failure
pg 416 |
|
|
Term
|
Definition
Normal Findings
7.4-10.4 fL
Indications: this test is helpful in the evaluation of platelet disorders especially thrombocytopenia
pg 419 |
|
|
Term
|
Definition
Age Range in mEq/L
Adult/edlerly 3.5-5
Child 3.4-4.7
Infant 4.1-5.3
Newborn 3.9-5.9
Critical Values: Adult <2.5 or >6.5 and Newborn <2.5 or >8
Indications: an important electrolyte for cardiac function, monitored in patients who take diuretics or heart medications.
Causes of Increased Levels: dietary intake, IV intake, acute or chronic renal failure because K excretion is decreased, addison disease, hypoaldosteronism, aldosterone-inhibiting diuretics (aldosterone enhances K excretion), crush injury, hemolysis, transfusion, infection, acidosis (H+ is driven into the cell and K is driven out), and dehydration. Symptoms: irritability, N/V, intestinal colic, diarrhea, changes in EKG (peaked T waves, widened QRS, and depressed ST).
Causes of Decreased Levels: dietary intake, IV intake, burns, GI disorders (diarrhea, vomiting, villous adnomas), diuretics (increase K excretion), hyperaldosteronism (aldosterone enhances K excretion), Cushing syndrome (aldosterone like effect), renal tubular acidosis (increased K excretion), licorice ingestion, alkalosis ( H+ ions are driven out of cells and K is driven in), Insulin administration (glucose and K are driven into cells), glucose administration, ascites (reduced blood flow stimulates secretion of aldosterone), renal artery stenosis (same as above), Cystic Fibrosis (K is secreted in sweat), trauma, surgery, burns. Symptoms: decreased contractility of smooth, skeletal and cardiac muscle, weakness, paralysis, hyporeflexia, ileus, increased cardiac sensitivity to digoxin, cardiac arrhythmias, flattened T waves and prominent U waves. |
|
|
Term
|
Definition
Normal Findings
Protein S: 60-130 % of normal activity
Protein C: 70-150 % of normal activity
(Protein C decreased in elderly and females
Indications: Part of evaluation of patients with coagulation disorders. |
|
|
Term
|
Definition
Age Range in g/dL
Adult
Total Protein: 6.4-8.3
Albumin: 3.5-5
Globulin: 2.3-3.4
Children
Total Protein
Premature infant 4.2-7.6
Newborn 4.6-7.4
Infant 6-6.7
Child 6.2-8
Albumin
Premature infant 3-4.2
Newborn 3.5-5.4
Infant 4.4-5.4
Child 4-5.9
Indications: Used to diagnose, evaluate and monitor the disease course in patients with cancer, intestinal/renal protein wasting states, immune disorders, liver dysfunction, impaired nutrition, and chronic edematous states.
pg441 |
|
|
Term
|
Definition
Normal Findings
11-12.5 seconds (85-100%)
Full anticoagulant therapy: > 1.5-2 times control value (20-30%)
INR .8-1.1
Critical Values: >20 sec. INR > 5.5
Indications: The PT is used to evaluate the adequacy of the extrinsic system and common pathway in the clotting mechanism.
pg 448 |
|
|
Term
Red Blood
Cell Count (RBC)
|
|
Definition
Age Range in 10^6/uL
Adult/Elderly
Male 4.7-6.1
Female 4.2-5.4
Child
2-8 weeks 4-6
2-6 months 3.5-5.5
6 months - 1 year 3.5-5.2
1-6 years 4-5.5
6-18 years 4-5.5
Newborn 4.8-7.1
Indications: closely related to H and H
pg 455 |
|
|
Term
|
Definition
Age Range in mEq/L
Adult/elderly 136-145
Child 136-145
Infant 134-150
Newborn 134-144
Critical Values: <120 or >160
Indications: monitor fluid and electrolyte levels
Causes of Hypernatremia: increased intake via diet or IV, decreased Na loss due to cushing syndrome (corticosteroids act like aldosterone) and hyperaldosteronism, excess free body water loss due to GI loss, sweating, thermal burns, dieabetes insipidus, osmotic diuresis (high Na concentration. Symptoms: dry mucous membranes, thirst, agitation, restlessness, hyperreflexia, mania and convulsions
Causes of Hyponatremia:Decreased Na intake via diet or IV, increased Na loss due to addison disease (aldosterone and corticosteroid levels are inadequate so Na is not reabsorbed and is excreted), diarrhea, vomiting, nasogastric aspiration, intraluminal bowel loss (ileus or bowel obstruction), diuretic, chronic renal insufficiency (kidney loses its reabsorptive ability), Large volume aspiration of pleural or peritoneal fluid (drowning -- leads to dilution of Na), increased free body water via excessive intake, hyperglycemia, Congestiv Heart Failure, peripheral edema, ascites, pleural effusion, intraluminal bowel loss (ileus or obstruction), syndrome of inappropriate or ectopic secretion of ADH (ADH prevents excretion of free water leads to dilution. Symptoms: weakness, confusion, lethargy, stupor, coma
pg479 |
|
|
Term
Thyroid Stimulating
Hormone |
|
Definition
Normal Findings
Adult 2-10 uUnit/mL
Newborn 3-18 uUnit/mL
Indications: this test is used to diagnose hypothyroidism and to differentiate it from secondary or tertiary hypothyroidism
pg 497 |
|
|
Term
|
Definition
Age Range in mcg/dL
1-3 days 11-22
1-2 weeks 10-16
1-4 months 8-16
1-5 years 7-15
5-10 years 6-13
10-15 years 5-12
Adult Male 4-12
Adult Female 5-12
Adult >60 years 5-11
Critical Values: Adult <2 mcg/dL if myxedema coma possible; >20 mcg/dL if thyroid storm possible; Newborn: <7 mcg/dL
Indications: Assess thyroid function, used to diagnose thyroid function and to monitor replacement and suppressive therapy. |
|
|
Term
|
Definition
Age Range ng/dL
1-3 days 100-174
1-11 months 105-245
1-5 years 105-270
6-10 years 95-240
11-15 years 80-215
16-20 years 80-215
20-50 years 70-205
>50 years 40-180
Indications: used to evaluate thyroid function, particularly in hyperthyroidism, also used ot monitor thyroid replacement and suppressive therapy.
pg 524 |
|
|
Term
|
Definition
Normal
Cardiac troponin T: <.2 ng/mL
Cardiac troponin I: <.03 ng/mL
Indications: used in patients with chest pain to determine if the pain is caused by cardiac ischemia. specific indicator of cardiac muscle injury and can be used to indicate risk of future cardiac events.
pg 530
|
|
|
Term
White Blood Cell Count
With Differential |
|
Definition
Normal Findings
Total
Adult/child >2 yrs 5000-10000/mm^3
Child</=2 yrs 6200-17000/mm^3
Newborn 9000-30000/mm^3
cell % per mm^3
neutrophils 55-70 2500-8000
lymphocytes 20-40 1000-4000
monocytes 2-8 100-700
eosinophils 1-4 50-500
basophils .5-1 25-100
Critical Values: WBCs <2500 or >30000/mm^3
Indications: evaluate patients with infection, neoplasm, allergy or immunosuppression. |
|
|